Recent Analyst Forecasts and Stock Ratings
Plus Therapeutics, Inc. FAQ's
Plus Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.
Plus Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.